Toxins Submission Guide: MDPI Process (2026)

Toxins is not a stronger version of a subscription toxinology journal, and it is not a weaker one. It is a different model. MDPI built it around speed and soundness-based review: the editorial question is whether the toxin work is methodologically sound and within scope, not whether it ranks among the most selective findings of the year. That model shapes how you should prepare the package.

Two features matter most.

• Section fit is specific. Toxins is organized by toxin class, so scope fit is assessed against a section rather than a vague "is this interesting" bar. The six sections are Animal Venoms, Bacterial Toxins, Marine and Freshwater Toxins, Mycotoxins, Plant Toxins, and Uremic Toxins.

• Double-blind review changes the upload. Toxins switched to double-blind review from the first issue of 2016 to reduce reviewer bias. Most MDPI journals are single-blind, so authors who treat Toxins like every other MDPI title submit a non-anonymized file and trip the pre-check.

The pre-check is fast and partly template-driven, so completeness is rewarded and incompleteness is punished early. A technically sound venom proteomics study with author names still on the title page can be returned before a reviewer sees it, while a competent, complete, in-scope, anonymized study moves quickly.

The core fit for most submissions is the original research article. It works best when the toxin is central, the characterization is reproducible from the text, the manuscript is anonymized, and the declarations and reporting package are complete on first upload.

Ask these questions before you submit:

• is the toxin the actual subject of the paper, or a tool used to make a point about something else?
• have you characterized the toxin beyond "it is toxic": structure, dose-response, mechanism, or validated detection?
• is the manuscript anonymized so a double-blind reviewer cannot identify the authors?
• are the ethics, biosafety, and data statements complete and specific, or still stub text?

If the answers are uncertain, the pre-check problem is usually more important than the science problem.

The pre-check editor is answering a short list of questions fast.

On scope, the editor asks whether the manuscript belongs in a toxinology journal and in which of the six sections. If the toxin relevance is thin or bolted on, the paper is redirected or returned. On characterization, the editor asks whether the toxin is actually studied as a toxin: a venom peptide needs sequence or structure and a target; a mycotoxin study needs identity and quantification; a detection method needs validation.

A paper that reports only that a crude extract kills cells, with no isolated compound and no mechanism, reads as preliminary.

On anonymization, the editor confirms the double-blind requirement is met. A title page with author names, an acknowledgement that names a grant holder, or a self-citation written as "in our previous work we showed" defeats double-blind and triggers a return. On integrity and completeness, the editor checks ethics, animal-welfare, biosafety, and data-availability statements, then looks for the declarations block. A manuscript missing Author Contributions, Funding, or Conflicts of Interest reads as not ready, even when the toxin science is fine.

Manuscript structure: Toxins expects a defined section set: Abstract, Keywords, Introduction, Results, Discussion, Materials and Methods (or Conclusions where appropriate), plus the declarations block. The abstract is the first thing the pre-check editor reads, so the toxin, its class, and the main finding all need to be visible there, with the target section inferable from the first sentence.

Characterization and methods readiness: Provide full experimental detail so results can be reproduced. For a venom or peptide toxin, report sequence, structure, or proteomic identification and a defined target or activity. For a mycotoxin or marine toxin, report identity, quantification, and matrix. For a detection or analytical method, report the figures-of-merit: limit of detection, limit of quantification, recovery, linearity, and matrix effect, with the relevant chromatograms or spectra as figures. A toxin paper that stops at a qualitative observation is the most common reviewer-stage friction point.

Declarations, ethics, and biosafety: Draft the Institutional Review Board statement, animal-ethics statement, biosafety statement for hazardous toxins, Author Contributions by initials, Funding, Data Availability, and Conflicts of Interest sections before you upload. These are not post-acceptance paperwork at MDPI; they are pre-check gates.

Anonymization for double-blind: Remove author names from the manuscript file and title page, replace identifying self-citations with neutral third-person phrasing, anonymize acknowledgements that name individuals or specific grants until acceptance, and clear the document metadata. MDPI's SuSy system collects author identities separately, so the manuscript file itself must stay anonymous.

In our pre-submission review work with Toxins submissions, four failure patterns generate the most consistent pre-check returns and reviewer friction, and they are testable against your own manuscript before you upload.

Across our toxinology and molecular pre-submission reviews, the pattern that surprises authors most is that the Toxins pre-check is not a quality filter in the Nature sense; it is a section-fit-and-characterization filter with an anonymization gate on top. The manuscripts that get returned fastest are rarely bad science. They are competent studies whose toxin is incidental, whose characterization stops too early, or whose file still names the authors. Manuscripts coming through pre-submission review for Toxins split cleanly along these four lines.

Toxin screening with no mechanism or structural characterization

The single most common pattern we see is a screen that ends at "this is toxic." A venom fraction, a plant extract, or a bacterial supernatant is shown to kill cells or larvae, and the paper stops there with no isolated compound, no structure, no dose-response curve, and no proposed mechanism of action.

Toxins is a toxinology journal, not a bioactivity-screening journal, so the section editor expects the toxin to be studied as a molecule: sequence or structure, a target, and a dose-response relationship. The testable version of this failure: read your own results and ask whether a reader could name the toxin and one mechanistic claim about how it acts.

If the strongest sentence in your paper is that an extract reduced viability by some percentage, the characterization is too thin for the section, and the fix is to isolate and identify the active compound and probe at least one mechanism before submitting.

Check whether your Toxins paper characterizes the toxin, not just its toxicity →

Detection-method papers with no validation or figures-of-merit

The second pattern is a detection or quantification method, common in the Mycotoxins and Marine and Freshwater Toxins sections, that reports a workflow but not its validation. We repeatedly see liquid chromatography or immunoassay methods for aflatoxin, ochratoxin, or saxitoxin that show a chromatogram and a calibration line but omit the figures-of-merit a method paper lives or dies on.

Reviewers in these sections expect a validation table covering limit of detection, limit of quantification, recovery, intra- and inter-day precision, linearity range, and matrix effect in the real sample. The testable version: build the validation table for your method before you write the discussion, and confirm every figure-of-merit has a number and a matrix. If your method section describes the procedure but cannot fill that table, the paper is not ready for review.

Check whether your Toxins detection method reports the figures-of-merit reviewers expect →

Extract-is-toxic studies with no isolated, characterized compound

The third pattern overlaps with the first but is worth separating because it is specific to plant, animal, and marine toxin work. The study demonstrates that a crude extract or whole venom is biologically active, then attributes the activity to an unspecified mixture without fractionation, purification, or identification of the responsible compound.

For the Plant Toxins and Animal Venoms sections, the section editor wants the toxin named, isolated where feasible, and characterized; a crude-extract activity report reads as a starting point rather than a finished study. The testable version: ask whether your paper identifies the molecule responsible for the activity it reports. If the active principle is "the extract" or "the venom" with no fractionation or compound identity, the work is a screening result, and a short communication framing or further purification is the honest fix.

Check whether your Toxins study isolates and characterizes the active compound →

Scope drift into general pharmacology where the toxin is incidental

The fourth pattern is scope drift. The manuscript is really a pharmacology, cell-biology, or drug-delivery study, and a toxin appears as a tool: a pore-forming toxin used to permeabilize membranes, a venom peptide used as a scaffold for an unrelated therapeutic claim, or a mycotoxin used as a generic cytotoxic stressor.

Toxins is section-based, so the editor has to place the paper, and a study where the toxin is incidental cannot be placed in any section. The testable version: read your abstract and ask whether the toxin or the application is the protagonist. If the toxin could be swapped for any other cytotoxic agent without changing the paper's conclusion, the work belongs in a pharmacology or cell-biology journal, and the fix is either to make the toxin the subject or to retarget the journal.

Check whether your Toxins paper keeps the toxin as the subject, not a tool →

Each of these is something you can check against your own draft before you commit the submission. This guide tells you what Toxins editors look for; the review tells you whether YOUR paper passes the pre-check before you upload. We have reviewed manuscripts targeting toxinology, biochemistry, and analytical-method journals, including Toxins and its open-access and subscription peers. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

Run a Toxins submission package check to see whether your toxin framing, characterization depth, and double-blind anonymization will clear the MDPI pre-check.

Toxins reports a median first decision near 20 days and median acceptance-to-publication near 2.8 days; author-reported SciRev data runs a little longer, with a first review round near 4.3 weeks. Treat these as planning ranges, not promises: specialized sections like Animal Venoms and Marine and Freshwater Toxins often run longer because reviewer search takes time in narrow subfields.

• Day 0: Submission via SuSy. The portal accepts the package and routes it to the section editor for pre-check.

• Days 1 to 3: Editorial pre-check. The editor screens section fit, anonymization for double-blind, ethics and biosafety completeness, integrity and plagiarism checks, and basic soundness.

The fastest returns happen here, before any reviewer is invited.

• Days 3 to 7: Reviewer invitation. Manuscripts that pass pre-check enter double-blind reviewer search, typically targeting two or more reviewers in the relevant toxin section.

• Days 7 to 20: Peer review and first decision. Reviewer reports return and the editor issues the first decision, with a median near 20 days from submission.

Major revision is the most common outcome for papers that clear pre-check.

• Days 20 to 40: Revision and acceptance. Revisions are usually requested on a short clock; resubmission and a second review cycle commonly land acceptance inside a few weeks for in-scope, complete packages.

• Days 40 to 45: Production and publication. Acceptance to publication runs near 2.8 days at median, so the slow part of the calendar is reviewer search and revision, not production.

This guide was researched and built from primary sources: the sources we checked include the Toxins Instructions for Authors, the journal's aims-and-scope and section pages, the MDPI announcement that moved Toxins to double-blind review from 2016, MDPI's research and publication ethics policy, SciRev's author-reported review-process data, and Manusights pre-submission review patterns from toxinology and molecular manuscripts deciding between Toxins and peer journals. We reviewed and compared current MDPI author guidance with recent Manusights work reviews from authors weighing Toxins, Toxicon, Archives of Toxicology, and Food Control. Last reviewed by the Manusights molecular and toxinology editorial team on 2026-06-06.

Source limitations: MDPI can update the APC, article-format details, abstract caps, and editorial-process numbers after this review date, so verify final administrative details against the official Toxins author pages before upload. Median timelines are reported by the journal and by SciRev and vary by section. Use this guide for the decision the official instructions cannot answer: whether your toxin framing, characterization depth, and double-blind anonymization are ready for the MDPI pre-check.

• Toxins journal profile and metrics
• Best toxicology journals
• Best biochemistry journals
• Best pharmacology journals
• Journal of Agricultural and Food Chemistry journal metrics

Before you upload, run your manuscript through a Toxins submission readiness check to catch the scope, characterization, and double-blind anonymization gaps the MDPI pre-check filters for. The check is free to run (/ai-review) and takes a single upload.